NSE: DRREDDY · 1 October 2026 · Dated market coverage
- DR. REDDY S LABORATORIES was trading2.75% lowerat ₹1,199.10 and near the lower end of the day’s trading range.
- Likely reason:Sectoral and broader market weakness.
- Cash volume was around1.09x the recent 20-day average, indicating above-normal participation.
Why Dr. Reddy S Laboratories Shares Are Falling 2.75% Today
Dr. Reddy’s Laboratories shares declined 2.75% during the session, trading near the lower end of the day’s range of ₹1,194.90 after opening at ₹1,225.90. Trading volumes came in at approximately 20.8 lakh shares, representing moderate participation compared to its 20-day average volume.
The broader market witnessed a sharp correction, with the benchmark Nifty falling 1.25% and the Nifty Pharma sector index dropping 0.84%. Dr. Reddy’s underperformed both the headline index and its sector peer group amid broader risk-off sentiment in equities.
Company developments include an exclusive distribution and marketing agreement signed with Takeda Biopharmaceuticals India for Qdenga in the private Indian market, alongside exchange clarifications sought regarding news reports. While these updates provide operational background, today’s downward price action appears largely aligned with broader sectoral weakness rather than a specific company-driven catalyst.
- Nifty down 1.25% and Nifty Pharma down 0.84%
- Dr. Reddy’s share price fell 2.75% alongside broader market retreat
Latest Company Developments
Ownership & Transaction Activity
Mutual Fund Holdings
What to Watch Next
- Upcoming financial results for the quarter ending September 30, 2026
- Developments regarding commercial rollout of the Qdenga vaccine partnership
Frequently Asked Questions
Why is DR. REDDY S LABORATORIES share price falling today?
The stock’s decline aligns closely with broader downward pressure across equity benchmarks and the pharmaceutical sector. No major negative corporate disclosures were reported to drive the sell-off independently.
How strong is trading participation today?
Participation is above normal. Volume is about 1.09x the latest 20-day average.
Other Dated Coverage
- Dr. Reddy’s Shares Dip 0.27% Amid Pharma Sector Consolidation — 5 October 2026
- Why Dr. Reddy’s Shares Fell 1.5% Today Amid Pharma Sector Weakness — 30 September 2026
- Dr. Reddy’s Lab Shares Rise: Why DRREDDY Stock is Moving Today — 29 September 2026
More Dr. Reddy S Laboratories news and dated analysis →
Article by: WittyTrades Research Desk